The US’s top agriculture official has raised concerns over a $44bn Chinese bid for Swiss seeds and chemicals group Syngenta, saying he is worried about the impact it may have on how Beijing approves US-made genetically modified organisms and on global food security.
The bid unveiled this month by state-owned conglomerate ChemChina for the Swiss group is set to be the largest overseas investment made by a Chinese company and is seen as a strategic play by Beijing to shore up its food security and bolster its access to leading agricultural technology.
Full content: Commercial Dispute Resolution
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Amex GBT Pushes Back Against DOJ Lawsuit Over CWT Acquisition
Jan 16, 2025 by
CPI
Belgium Opens Antitrust Probe into AB InBev’s Market Practices
Jan 16, 2025 by
CPI
Tech Groups Sue CFPB Over New Rule on Digital Wallet Oversight
Jan 16, 2025 by
CPI
EU Antitrust Chief Ribera: Consumer Protections Remain Top Priority
Jan 16, 2025 by
CPI
Mylan Agrees to $73.5 Million Settlement Over EpiPen Pricing Allegations
Jan 16, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand